healthcare

ARK-FutureFirst

Royal London AM’s Mike Fox

Zealand Pharma A/S

Partner Content: Peter Hughes, Portfolio Manager of the Life Changing Treatment Strategy at Redwheel, sponsor of the Funds to Watch 2024 event, discusses the team's patients-first approach to healthcare investing and how they see the current climate for...

Rudi Van den Eynde to retire in 2025

£2 tax free for each £1 invested

US still offering the most biotech names

In the wake of recent underperformance, healthcare is entering the new year with compressed valuations just as innovation picks up and a post-COVID reset winds down. That should make for a positive outlook, say Portfolio Managers Andy Acker and Dan Lyons.

UK tipped as best performing region

Though healthcare may have flown under the market’s radar this year, the sector’s attractive valuations and new growth opportunities are not to be overlooked, say Janus Henderson's Portfolio Managers Andy Acker and Dan Lyons.